Busca


Filtros atuais:
Iniciar uma nova busca
Adicionar filtros:

Use filtros para refinar os resultados da pesquisa.


Resultados 7561-7570 de 8662 (Tempo de busca: 0.014 Segundos).
Resultados em Itens:
Data de publicaçãoTítuloAutor(es)
2012Parallel Down-Regulation of FOXO1, PPAR? and Adiponectin mRNA Expression in Visceral Adipose Tissue of Class III Obese IndividualsHammes, Thais Ortiz; Costa, Cíntia dos Santos; Rohden, Francieli; Margis, Rogério; ALMEIDA, JUSSARA CARNEVALE DE; Alexandre Vontobel Padoin; Mottin, Cláudio Cora; Regina Maria Vieira da Costa Guaragna
2015Acute post-infectious cerebellitisMARTINS, WILLIAM ALVES; CRISTOVAM, RAFAEL DO AMARAL; André Luis Fernandes Palmini
2014Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study).Paulo Caramelli; Jerson Laks; André Luis Fernandes Palmini; Ricardo Nitrini; Marcia Lorena Chaves; Orestes Forlenza; Francisco Vale; maira Toninandel Barbosa; Cassio Bottino; Helenice Charchat-Fichman; FL Lawson
2015Periodic lateralized epileptiform discharges (PLEDs) in herpetic encephalitisMARTINS, WILLIAM ALVES; André Luis Fernandes Palmini
2016The Management of Immune-related Adverse Events Associated with Immune Checkpoint BlockadeAndré Poisl Fay; Raphael Brandao Moreira; Paulo R. S.Nunes Filho; Caroline Albuquerque; Barrios
2015Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker studyAndré Poisl Fay; SIGNORETTI, SABINA; CALLEA, MARCELLA; TEL', GABRIELA H; MCKAY, RANA R; SONG, JIAXI; CARVO, INGRID; LAMPRON, MEGAN E; KAYMAKCALAN, MARINA D; POLI-DE-FIGUEIREDO, CARLOS E; BELLMUNT, JOAQUIM; HODI, F STEPHEN; FREEMAN, GORDON J; ELFIKY, AYMEN; CHOUEIRI, TONI K
2016Número necessário a tratar (NNT) e custo por evento evitado (COPE) de enzalutamida e acetato de abiraterona para o tratamento de câncer de próstata resistente à castração que falharam a terapia de privação de androgênioSTEFANI, STEPHEN; SASSE, ANDRÉ; André Poisl Fay; KIM, HELLEN; ABADI, MARCIA; TEICH, VANESSA; LOPES, GILBERTO
2016Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaDE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA; URUN, YUKSEL; CAROL, HALLIE A.; André Poisl Fay; SIGNORETTI, SABINA; KWIATKOWSKI, DAVID J.; MCDERMOTT, DAVID F.; FREEDMAN, MATTHEW; POMERANTZ, MARK M.; CHOUEIRI, TONI K.
2015HER2 as a target in invasive urothelial carcinomaBELLMUNT, JOAQUIM; WERNER, LILLIAN; BAMIAS, ARISTOTLE; André Poisl Fay; PARK, RACHEL S.; RIESTER, MARKUS; SELVARAJAH, SHAMINI; BARLETTA, JUSTINE A.; BERMAN, DAVID M.; DE MUGA, SILVIA; SALIDO, MARTA; GALLARDO, ENRIQUE; ROJO, FEDERICO; GUANCIAL, ELIZABETH A.; BAMBURY, RICHARD; MULLANE, STEPHANIE A.; CHOUEIRI, TONI K.; LODA, MASSIMO; STACK, EDWARD; ROSENBERG, JONATHAN
2015Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspectiveStephen Doral Stefani; Vanessa Teich; André Poisl Fay; Marcia Abadi; Scott Flanders; Cat Bui; Andre Sasse